Menu

Study Shows ALS Patients May Benefit From More Glucose

A study co-authored by Barrow researchers Dr. Rita Sattler and Dr. Robert Bowser found that people with amyotrophic lateral sclerosis (ALS) may benefit from more glucose. It is widely known that people with the neurodegenerative…

Dr. Jeremy Shefner Announces Results of FORTITUDE-ALS Trial

Dr. Jeremy Shefner, chair of the Department of Neurology at Barrow, recently presented the results of the FORTITUDE-ALS trial at the annual meeting of the American Academy of Neurology in Philadelphia. The Phase 2 trial…

Barrow, CloudMedx to Use AI to Better Understand ALS Progression

The Gregory W. Fulton ALS and Neuromuscular Disease Center at Barrow is collaborating with a healthcare artificial intelligence (AI) company to track disease progression in people with amyotrophic lateral sclerosis (ALS). Currently, little is known…

Barrow Neurologist Discusses Football and ALS

Dr. Shafeeq Ladha, director of the Gregory W. Fulton ALS and Neuromuscular Disease Center at Barrow, weighed in on the discussion of amyotrophic lateral sclerosis (ALS) in football players. Retired football player Tim Green suspects…

About Barrow Neurological Institute

Since our doors opened as a regional specialty center in 1962, we have grown into one of the premier destinations in the world for neurology and neurosurgery. Our experienced, highly skilled, and comprehensive team of neurological specialists can provide you with a complete spectrum of care–from diagnosis through outpatient neurorehabilitation–under one roof. Barrow Neurological Institute: Discover. Educate. Heal.